KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Michael J Kratsios, Director, Office of Science and Technology Policy, disclosed 2 transactions

· Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)

2025-12-26 · purchaseVanguard Tax-Exempt Bond Index Fund ETFShares — $1,001 - $15,000
2025-12-26 · purchaseVanguard Dividend Appreciation Index Fund ETFClass Shares — $1,001 - $15,000

Original filing document